Goldman Sachs
ZEPP

Goldman Sachs’s Zepp Health ZEPP Stock Holding History

Goldman Sachs’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-117,804
Closed -$1.41M – 7052
2026
Q1 		$1.41M Buy
117,804
+92,542
+366% +$1.89M ﹤0.01% 4832
2025
Q4 		$681K Buy
+25,262
New +$901K ﹤0.01% 5410
2022
Q3 		– Sell
-6,467
Closed -$48K – 6568
2022
Q2 		$48K Buy
6,467
+1,151
+22% +$10.6K ﹤0.01% 6035
2022
Q1 		$61K Sell
5,316
-155,216
-97% -$2.51M ﹤0.01% 6228
2021
Q4 		$3.24M Sell
160,532
-257,749
-62% -$7.73M ﹤0.01% 3811
2021
Q3 		$13.4M Buy
418,281
+19,006
+5% +$785K ﹤0.01% 2431
2021
Q2 		$18.8M Buy
399,275
+12,496
+3% +$520K ﹤0.01% 2103
2021
Q1 		$16.7M Buy
386,779
+438
+0.1% +$25.5K ﹤0.01% 2088
2020
Q4 		$18.3M Sell
386,341
-23,328
-6% -$1.16M ﹤0.01% 1932
2020
Q3 		$21.1M Buy
409,669
+21,170
+5% +$1.16M 0.01% 1700
2020
Q2 		$19.2M Sell
388,499
-157,512
-29% -$7.26M 0.01% 1717
2020
Q1 		$28.7M Buy
546,011
+39,668
+8% +$2.15M 0.01% 1245
2019
Q4 		$24.3M Buy
506,343
+2,776
+0.6% +$116K 0.01% 1701
2019
Q3 		$20.1M Buy
503,567
+16,038
+3% +$673K 0.01% 1772
2019
Q2 		$19.5M Sell
487,529
-54
-0% -$2.25K 0.01% 1872
2019
Q1 		$25.5M Sell
487,583
-48,768
-9% -$2.63M 0.01% 1661
2018
Q4 		$21.1M Buy
536,351
+11,226
+2% +$441K 0.01% 1769
2018
Q3 		$22.5M Sell
525,125
-635
-0.1% -$25.6K 0.01% 1832
2018
Q2 		$20.7M Buy
525,760
+26,848
+5% +$1.1M 0.01% 1849
2018
Q1 		$21.2M Buy
+498,912
New +$22.1M 0.01% 1817

Other funds holding ZEPP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs's ZEPP Position: Q2 2026 in Review

Goldman Sachs sold out of Zepp Health (ZEPP) in Q2 2026, closing a stake of 117,804 shares — an estimated $1.41M sold.

Goldman Sachs first reported a position in ZEPP in Q1 2018 and held it in 20 quarters. The position peaked at $28.7M in Q1 2020. 28 funds tracked by Wall St. Rank hold ZEPP as of Q2 2026.

  • Goldman Sachs reported no remaining Zepp Health position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 117,804 Zepp Health shares in Q2 2026, an estimated $1.41M.
  • Goldman Sachs first reported a position in Zepp Health in Q1 2018 and held it in 20 quarters.
  • Goldman Sachs's Zepp Health position peaked at $28.7M in Q1 2020.
  • 28 funds tracked by Wall St. Rank held Zepp Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.